Marco Traub | Chief Executive Officer
TESCT - The Trans European Stem Cell Therapy Society
Dr. Marco Traub has gained considerable experience in several research, management, and educational projects over the past 25 years. He is the founder of the Trans European Stem Cell Therapy Consortium (TESCT) and acts since 2005 as Chair of the TESCT consortium and as EU-Commission Expert (EX2013D138520) in FP7 and the Innovative Medicine Initiative (IMI 1+2) 2018, which is a public private partnership between the European Commission (FP6/FP7/Horizon 2020, Health and Life Sciences) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) and COST framework for Switzerland.
Appearances:
Festival of Biologics Day 1 @ 15:20
Development and Dissemination of affordable cell based immunotherapies for low income countries
Dr. Marco Traub is a Neuroscientist who gained considerable experience in a number of stem cell expert and management and educational roles over the past 20 years. He acts as CEO of the Trans European Stem Cell Therapy Consortium (TESCT) and as an EU-Commission expert in FP7 and the Innovative Medicine Initiative (IMI JU) 2018, which is a public private partnership between the European Commission (FP6/FP7/ Horizon 2020, Health and Life sciences) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) and COST framework for Switzerland.
While in Switzerland and UK, he specialised in Biotechnology, with a focus on PCR technology and peptide synthesis and their GMP production. In the same period he was Assistant Professor at the Medical School at the University of Kansas City. There he was involved in research projects and teaching neuro-anatomy and opiate receptor pharmacology as well as in molecular medicine.
Festival of Biologics Day 1 @ 15:20
Development and Dissemination of affordable cell based immunotherapies for low income countries and hospitals
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events